Clinically, enhanced expression of LEPR was observed in human oesophageal, breast, gastric, colon and gastric cancer tissues and could predict cancer progression in bladder, endometrial and ovarian cancer [36–38]. The gene discussed is LEPR; the disease is ovarian carcinoma.